• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）在胃肠道中的表现：治疗意义

SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic Implications.

作者信息

Jefremow André, Neurath Markus F

机构信息

Department of Internal Medicine 1, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany.

出版信息

Visc Med. 2021 Feb;37(1):63-69. doi: 10.1159/000513180. Epub 2020 Nov 24.

DOI:10.1159/000513180
PMID:33693046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7802000/
Abstract

BACKGROUND

About 1 year ago a novel virus - SARS-CoV-2 - began to spread around the world. It can lead to the disease COVID-19, which has caused more than 1 million deaths already.

SUMMARY

While it was first recognized as a disease leading to pneumonia and lung failure, we know by now that COVID-19 is more complex. COVID-19 is a systemic hyperinflammatory disease affecting not only the lungs, but also many other organs. Especially the gastrointestinal (GI) tract is often involved in COVID-19.

KEY MESSAGES

This review provides an overview of the different affected organs of the GI tract and offers information on how gastroenterologists should take care of their patients with different GI disorders.

摘要

背景

大约一年前，一种新型病毒——严重急性呼吸综合征冠状病毒2（SARS-CoV-2）——开始在全球传播。它可导致新冠肺炎疾病，该疾病已造成100多万人死亡。

总结

虽然它最初被认为是一种导致肺炎和肺衰竭的疾病，但我们现在知道新冠肺炎更为复杂。新冠肺炎是一种全身性炎症性疾病，不仅影响肺部，还影响许多其他器官。尤其是胃肠道经常受到新冠肺炎的影响。

关键信息

本综述概述了胃肠道不同的受累器官，并提供了关于胃肠病学家应如何照顾患有不同胃肠道疾病患者的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d0e/7923939/f9e940ca98d0/vis-0037-0063-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d0e/7923939/22559f34cd45/vis-0037-0063-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d0e/7923939/f9e940ca98d0/vis-0037-0063-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d0e/7923939/22559f34cd45/vis-0037-0063-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d0e/7923939/f9e940ca98d0/vis-0037-0063-g02.jpg

相似文献

1
SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic Implications.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）在胃肠道中的表现：治疗意义
Visc Med. 2021 Feb;37(1):63-69. doi: 10.1159/000513180. Epub 2020 Nov 24.
2
COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist.新型冠状病毒肺炎与胃肠道疾病：对胃肠病学家的启示。
Dig Dis. 2021;39(2):119-139. doi: 10.1159/000512152. Epub 2020 Oct 9.
3
Twelve Months with COVID-19: What Gastroenterologists Need to Know.《与 COVID-19 相伴的十二个月：胃肠病学家需要了解的情况》。
Dig Dis Sci. 2022 Jul;67(7):2771-2791. doi: 10.1007/s10620-021-07158-0. Epub 2021 Jul 31.
4
Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications.SARS-CoV-2 的胃肠道表现：传播、发病机制、免疫调节、微生物失调和临床意义。
Viruses. 2023 May 24;15(6):1231. doi: 10.3390/v15061231.
5
Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.宿主对 SARS-CoV2 及现有肝脏和胃肠道疾病中新兴变异株的反应。
Front Cell Infect Microbiol. 2021 Oct 25;11:753249. doi: 10.3389/fcimb.2021.753249. eCollection 2021.
6
A mini-review on the impact of COVID 19 on vital organs.关于 COVID-19 对重要器官影响的小型综述。
Biomed Pharmacother. 2021 Nov;143:112158. doi: 10.1016/j.biopha.2021.112158. Epub 2021 Sep 4.
7
Gastrointestinal manifestations in COVID-19.新型冠状病毒肺炎的胃肠道表现。
Trans R Soc Trop Med Hyg. 2021 Dec 2;115(12):1362-1388. doi: 10.1093/trstmh/trab042.
8
COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.COVID-19 大流行：胃肠道的病理生理学和表现。
World J Gastroenterol. 2020 Aug 21;26(31):4579-4588. doi: 10.3748/wjg.v26.i31.4579.
9
Autoimmunity and COVID-19 - The microbiotal connection.自身免疫与 COVID-19：微生物组的关联。
Autoimmun Rev. 2021 Aug;20(8):102865. doi: 10.1016/j.autrev.2021.102865. Epub 2021 Jun 10.
10
COVID-19 and gastrointestinal system: A brief review.新型冠状病毒肺炎与消化系统：简要综述。
Biomed J. 2021 Jun;44(3):245-251. doi: 10.1016/j.bj.2021.01.001. Epub 2021 Jan 16.

引用本文的文献

1
Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies.抗病毒和抗炎的植物源生物活性化合物及其在治疗COVID-19相关病症中的潜在用途。
J Xenobiot. 2022 Oct 8;12(4):289-306. doi: 10.3390/jox12040020.
2
Microscopic colitis: Etiopathology, diagnosis, and rational management.显微镜下结肠炎：病因学、诊断和合理治疗。
Elife. 2022 Aug 1;11:e79397. doi: 10.7554/eLife.79397.
3
Risk, Course, and Effect of SARS-CoV-2 Infection in Children and Adults with Chronic Inflammatory Bowel Diseases.

本文引用的文献

1
Severe acute respiratory syndrome coronavirus-2 infection and the gut-liver axis.严重急性呼吸综合征冠状病毒 2 感染与肠-肝轴。
J Dig Dis. 2020 Dec;21(12):687-695. doi: 10.1111/1751-2980.12951.
2
Effect of IBD medications on COVID-19 outcomes: results from an international registry.IBD 药物对 COVID-19 结局的影响：来自国际注册研究的结果。
Gut. 2021 Apr;70(4):725-732. doi: 10.1136/gutjnl-2020-322539. Epub 2020 Oct 20.
3
Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling.
患有慢性炎症性肠病的儿童和成人感染新型冠状病毒的风险、病程及影响
Children (Basel). 2021 Aug 30;8(9):753. doi: 10.3390/children8090753.
严重急性呼吸综合征冠状病毒2附着受体血管紧张素转换酶2在克罗恩病中减少，并受微生物和炎症信号调节。
Gastroenterology. 2021 Feb;160(3):925-928.e4. doi: 10.1053/j.gastro.2020.10.021. Epub 2020 Oct 17.
4
COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist.新型冠状病毒肺炎与胃肠道疾病：对胃肠病学家的启示。
Dig Dis. 2021;39(2):119-139. doi: 10.1159/000512152. Epub 2020 Oct 9.
5
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.慢性肝病患者感染 SARS-CoV-2 后的结局：一项国际注册研究。
J Hepatol. 2021 Mar;74(3):567-577. doi: 10.1016/j.jhep.2020.09.024. Epub 2020 Oct 6.
6
Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study.巴瑞替尼改善了 COVID-19 肺炎患者接受皮质类固醇治疗后的呼吸功能：一项观察性队列研究。
Rheumatology (Oxford). 2021 Jan 5;60(1):399-407. doi: 10.1093/rheumatology/keaa587.
7
Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?英夫利昔单抗治疗的溃疡性结肠炎患者中的轻度 COVID-19 症状：持续的抗 TNF 治疗能否预防病毒过度炎症反应并避免不良后果？
Visc Med. 2020 Aug;36(4):338-342. doi: 10.1159/000508740. Epub 2020 Jun 5.
8
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.肝移植受者感染 SARS-CoV-2 后的结局：一项国际注册研究。
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28.
9
Prevalence, Risk Factors, and Outcomes of Hospitalized Patients With Coronavirus Disease 2019 Presenting as Acute Pancreatitis.2019冠状病毒病以急性胰腺炎为表现的住院患者的患病率、危险因素及预后
Gastroenterology. 2020 Dec;159(6):2226-2228.e2. doi: 10.1053/j.gastro.2020.08.044. Epub 2020 Aug 26.
10
The JAK1/3 inhibitor tofacitinib suppresses T cell homing and activation in chronic intestinal inflammation.JAK1/3抑制剂托法替布可抑制慢性肠道炎症中的T细胞归巢和活化。
J Crohns Colitis. 2020 Aug 18. doi: 10.1093/ecco-jcc/jjaa162.